| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/2010 | US7670773 detecting Rett syndrome, a neuropsychiatric disorder |
| 03/02/2010 | US7670771 Assessing human predisposition to a febrile seizure disorder |
| 03/02/2010 | US7670766 Early detection of flaviviruses using the NS1 glycoprotein |
| 03/02/2010 | US7670610 Recombinant BCG vaccine |
| 03/02/2010 | US7670603 Using toll-like receptor polypeptides to generate atibodies for use in treatment and prevention of septic shock, inflammation and viral infection |
| 03/02/2010 | US7670602 Concatameric immunoadhesion molecule |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | US7670595 Fc-interferon-beta fusion proteins |
| 03/02/2010 | CA2390659C Ny-eso-1 peptide derivatives, and uses thereof |
| 03/02/2010 | CA2314429C Insect-resistant transgenic plants and methods for improving .delta.-endotoxin activity against target insects |
| 03/02/2010 | CA2190359C Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection |
| 03/01/2010 | CA2734807A1 Nematode-resistant transgenic plants |
| 02/25/2010 | WO2010022279A1 Antibodies and related molecules that bind to 58p1d12 proteins |
| 02/25/2010 | WO2010022260A2 Novel toxin-antitoxin system |
| 02/25/2010 | WO2010022244A1 Production of l-ribose and other rare sugars |
| 02/25/2010 | WO2010022198A2 T cell receptors and related materials and methods of use |
| 02/25/2010 | WO2010021846A2 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae |
| 02/25/2010 | WO2010021822A2 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites |
| 02/25/2010 | WO2010021738A2 Method for producing double-crosslinked collagen |
| 02/25/2010 | WO2010021697A2 Antibodies to ccr2 |
| 02/25/2010 | WO2010021126A1 Glycoprotein production method and screening method |
| 02/25/2010 | WO2010021112A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 02/25/2010 | WO2010021111A1 Inhbb epitope peptides and vaccines containing the same |
| 02/25/2010 | WO2010020825A2 Urocortin 3 fragments and analogs, their preparation and use as antidepressive and anxiolytic agents |
| 02/25/2010 | WO2010020811A1 Non-cytotoxic fusion proteins comprising egf muteins |
| 02/25/2010 | WO2010020767A2 Glp-1 fusion polypeptides |
| 02/25/2010 | WO2010020766A2 Interleukin fusion polypeptides |
| 02/25/2010 | WO2010020690A1 Recombinantly produced human factor viii and ix |
| 02/25/2010 | WO2010020657A1 Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| 02/25/2010 | WO2010020645A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 02/25/2010 | WO2010020555A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/25/2010 | WO2010020143A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 02/25/2010 | WO2010020042A1 Soluble canola protein isolate production from protein micellar mass |
| 02/25/2010 | WO2010020039A1 Preparation of canola protein isolate from canola oil seeds ("blendertein") |
| 02/25/2010 | WO2010020038A1 Production of canola protein isolate without heat treatment |
| 02/25/2010 | WO2010020036A1 Siderophore-mediated iron uptake in bacterial infection |
| 02/25/2010 | WO2010003108A3 TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 02/25/2010 | WO2009155626A3 Functionally intact virus-inactivated fibrinogen remaining stable during storage |
| 02/25/2010 | WO2009151542A3 Nicotinic acid receptor ligands |
| 02/25/2010 | WO2009147180A3 Microbicidal peptides of trichoderma reesei |
| 02/25/2010 | WO2009146886A3 Antibacterial peptides |
| 02/25/2010 | WO2009137763A3 Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria |
| 02/25/2010 | WO2009137632A3 Hiv immunogen and method of making and using same |
| 02/25/2010 | WO2009135118A3 Lyme disease vaccine |
| 02/25/2010 | WO2009129250A3 Meal-time insulin analogues of enhanced stability |
| 02/25/2010 | WO2009126308A3 Compositions and methods for vaccine and virus production |
| 02/25/2010 | WO2009114702A3 Recombinant production of authentic human proteins using human cell expression systems |
| 02/25/2010 | WO2009104092A3 Escherichia coli immunogens with improved solubility |
| 02/25/2010 | WO2009102569A4 Cell lines and methods for making and using them |
| 02/25/2010 | WO2009093917A3 Production of the opioid peptide biphaline |
| 02/25/2010 | WO2009063069A3 Protein purification and endotoxin removal |
| 02/25/2010 | WO2009036092A9 Mitochondria-targeted anti-tumour agents |
| 02/25/2010 | WO2009010976A3 Compositions and methods for purifying and crystallizing molecules of interest |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100050303 Antimicrobial Agents from Microbial Genomes |
| 02/25/2010 | US20100050296 Preparation of organisms with faster growth and/or higher yield |
| 02/25/2010 | US20100050294 Method for modifying insect resistance of plants by utilizing rnai technique |
| 02/25/2010 | US20100050292 Galactosyltransferase |
| 02/25/2010 | US20100049847 System and Method for Monitoring and Analyzing Internet Traffic |
| 02/25/2010 | US20100049491 Method and System for Optimizing Minigenes and Peptides Encoded Thereby |
| 02/25/2010 | US20100048880 Starch Binding Domain and Use Thereof |
| 02/25/2010 | US20100048879 Multimerised hiv fusion inhibitors |
| 02/25/2010 | US20100048878 Human gene |
| 02/25/2010 | US20100048876 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation |
| 02/25/2010 | US20100048875 Soluble Canola Protein Isolate Production from PMM ("C307") |
| 02/25/2010 | US20100048874 Colour reduction in canola protein isolate |
| 02/25/2010 | US20100048873 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use |
| 02/25/2010 | US20100048872 Methods for making proteins containing free cysteine residues |
| 02/25/2010 | US20100048871 Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids |
| 02/25/2010 | US20100048870 Identifying components of a network having high importance for network integrity |
| 02/25/2010 | US20100048869 Agent comprising g-csf for prevention and treatment of diabetic peripheral neuropathy |
| 02/25/2010 | US20100048868 Polypeptides Having Binding Affinity for Her2 |
| 02/25/2010 | US20100048864 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
| 02/25/2010 | US20100048863 Growth factor which acts through erb b-4 rtk |
| 02/25/2010 | US20100048862 Ferroportin1 nucleic acids, proteins, antibodies and methods |
| 02/25/2010 | US20100048637 Cyclohexylamines, phenylamines and uses thereof |
| 02/25/2010 | US20100048487 Novel cell penetrating peptide |
| 02/25/2010 | US20100048486 Use of Soluble Fgl2 As An Immunosuppressant |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048483 Polymeric benzyl carbonate-derivatives |
| 02/25/2010 | US20100048480 Production of anti-microbial peptides |
| 02/25/2010 | US20100048478 Fn14/trail fusion proteins |
| 02/25/2010 | US20100048477 Method for prevention of platelet aggregation employing an rgd-enriched gelatine-like proteins |
| 02/25/2010 | US20100048476 Novel use of bacteriocin derived from enterococcus faecalis sl-5 |
| 02/25/2010 | US20100048473 Modified Protein Polymers |
| 02/25/2010 | US20100048472 Albumin Fusion Proteins |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048468 Glp-1 compounds |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048465 Peptide mimics of melanocyte stimulating hormone |
| 02/25/2010 | US20100048464 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/25/2010 | US20100048460 Selective vpac2 receptor peptide agonists |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/25/2010 | US20100048456 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/25/2010 | US20100048413 Ob fold domains |
| 02/25/2010 | US20100047923 Two helix binders |
| 02/25/2010 | US20100047895 Methods for purification of bacterial cells and cell components |
| 02/25/2010 | US20100047871 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047868 Tumour Suppressor Protein |